| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +15.29% | -2.33% | +17.63% | +17.63% | — |
| 14d | 1 | +100.00% | +16.47% | +0.25% | +16.22% | +16.22% | — |
| 30d | 1 | +0.00% | -7.06% | -1.80% | -5.26% | -5.26% | — |
| 60d | 1 | +0.00% | -4.71% | -4.54% | -0.17% | -0.17% | — |
| 90d | 1 | +0.00% | -5.29% | -1.11% | -4.19% | -4.19% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 72,981 | — | — | 146,953 | May 18, 2026 | May 20, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $1.92 | $1.2K | 73,972 | May 14, 2026 | May 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 186,728 | — | — | 186,728 | Mar 1, 2026 | Mar 3, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 723 | $1.63 | $1.2K | 74,585 | Feb 14, 2026 | Feb 18, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 10,000 | $1.72 | $17.2K | 75,308 | Jan 13, 2026 | Jan 15, 2026 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $2.24 | $1.4K | 65,308 | Nov 14, 2025 | Nov 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $1.39 | $852 | 65,921 | Aug 14, 2025 | Aug 18, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $1.14 | $699 | 66,534 | May 14, 2025 | May 16, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 140,540 | — | — | 140,540 | Mar 1, 2025 | Mar 4, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 724 | $5.42 | $3.9K | 67,147 | Feb 14, 2025 | Feb 19, 2025 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $7.92 | $4.9K | 67,871 | Nov 14, 2024 | Nov 18, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $7.02 | $4.3K | 68,484 | Aug 14, 2024 | Aug 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 10,000 | — | — | 86,615 | May 17, 2024 | May 21, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 10,000 | $1.04 | $10.4K | 69,097 | May 17, 2024 | May 21, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 613 | $8.36 | $5.1K | 59,097 | May 14, 2024 | May 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 90,090 | — | — | 90,090 | Mar 1, 2024 | Nov 27, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 723 | $3.40 | $2.5K | 59,710 | Feb 14, 2024 | Feb 16, 2024 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 2,450 | $5.08 | $12.4K | 60,433 | Nov 14, 2023 | Nov 16, 2023 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | SALE Chief Operating Officer | 9,225 | — | — | 96,615 | Jun 5, 2023 | Jun 6, 2023 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASE Chief Operating Officer | 9,225 | $1.04 | $9.6K | 62,883 | Jun 5, 2023 | Jun 6, 2023 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 33,383 | — | — | 53,658 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |
| ACRV ACRIVON THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 100,150 | — | — | 100,150 | Nov 14, 2022 | Nov 16, 2022 ↗ | View → |